Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uekama

Showing results (71-80 of 249) with videos related to

Pageof 25
Sort By:
Chemical & Pharmaceutical Bulletin|June 1, 1984
Effects of beta- and gamma-cyclodextrins on release of betamethasone from ointment basesM Otagiri, T Fujinaga, A Sakai, et al.
Acta Pharmaceutica Suecica|January 1, 1983
Improvements to some pharmaceutical properties of flurbiprofen by beta- and gamma-cyclodextrin complexationsM Otagiri, T Imai, N Matsuo, et al.
Chemical & Pharmaceutical Bulletin|February 24, 2001
Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexationN Ono, F Hirayama, H Arima, et al.
FEBS Letters|February 15, 2003
Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cellsKiyokazu Yunomae, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Drug Targeting|June 17, 2006
Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomesHidetoshi Arima, Yoshiyuki Hagiwara, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|June 24, 2006
Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated ratsTakumi Hara, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|October 13, 2007
Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNAToshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release systemTaishi Higashi, Fumitoshi Hirayama, Hidetoshi Arima, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1988
Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexationT Imai, M Otagiri, H Saitô, et al.
Journal of Pharmaceutical Sciences|October 9, 1999
Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activityF Hirayama, S Mieda, Y Miyamoto, et al.
Pageof 25

Showing results (71-80 of 249) with videos related to

Sort By:
Pageof 25
Chemical & Pharmaceutical Bulletin|June 1, 1984
Effects of beta- and gamma-cyclodextrins on release of betamethasone from ointment basesM Otagiri, T Fujinaga, A Sakai, et al.
Acta Pharmaceutica Suecica|January 1, 1983
Improvements to some pharmaceutical properties of flurbiprofen by beta- and gamma-cyclodextrin complexationsM Otagiri, T Imai, N Matsuo, et al.
Chemical & Pharmaceutical Bulletin|February 24, 2001
Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexationN Ono, F Hirayama, H Arima, et al.
FEBS Letters|February 15, 2003
Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cellsKiyokazu Yunomae, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Drug Targeting|June 17, 2006
Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomesHidetoshi Arima, Yoshiyuki Hagiwara, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|June 24, 2006
Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated ratsTakumi Hara, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|October 13, 2007
Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNAToshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release systemTaishi Higashi, Fumitoshi Hirayama, Hidetoshi Arima, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1988
Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexationT Imai, M Otagiri, H Saitô, et al.
Journal of Pharmaceutical Sciences|October 9, 1999
Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activityF Hirayama, S Mieda, Y Miyamoto, et al.
Pageof 25